Results
|
2321.
|
|
|
2322.
|
Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging people living with HIV. [electronic resource] by
- Courlet, Perrine
- Stader, Felix
- Guidi, Monia
- Alves Saldanha, Susana
- Stoeckle, Marcel
- Cavassini, Matthias
- Battegay, Manuel
- Buclin, Thierry
- Decosterd, Laurent Arthur
- Marzolini, Catia
Producer: 20210125
In:
AIDS (London, England) vol. 34
Availability: No items available.
|
|
2323.
|
|
|
2324.
|
Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial. [electronic resource] by
- Wijting, Ingeborg
- Rokx, Casper
- Boucher, Charles
- van Kampen, Jeroen
- Pas, Suzan
- de Vries-Sluijs, Theodora
- Schurink, Carolina
- Bax, Hannelore
- Derksen, Maarten
- Andrinopoulou, Eleni-Rosalina
- van der Ende, Marchina
- van Gorp, Eric
- Nouwen, Jan
- Verbon, Annelies
- Bierman, Wouter
- Rijnders, Bart
Producer: 20180917
In:
The lancet. HIV vol. 4
Availability: No items available.
|
|
2325.
|
|
|
2326.
|
|
|
2327.
|
Minimal effects of ritonavir and efavirenz on the pharmacokinetics of raltegravir. [electronic resource] by
- Iwamoto, Marian
- Wenning, Larissa A
- Petry, Amelia S
- Laethem, Martine
- De Smet, Marina
- Kost, James T
- Breidinger, Sheila A
- Mangin, Eric C
- Azrolan, Neal
- Greenberg, Howard E
- Haazen, Wouter
- Stone, Julie A
- Gottesdiener, Keith M
- Wagner, John A
Producer: 20090127
In:
Antimicrobial agents and chemotherapy vol. 52
Availability: No items available.
|
|
2328.
|
|
|
2329.
|
Prevention of HIV protease inhibitor-induced dysregulation of hepatic lipid metabolism by raltegravir via endoplasmic reticulum stress signaling pathways. [electronic resource] by
- Cao, Risheng
- Hu, Yiqiao
- Wang, Yun
- Gurley, Emily C
- Studer, Elaine J
- Wang, Xuan
- Hylemon, Phillip B
- Pandak, William M
- Sanyal, Arun J
- Zhang, Luyong
- Zhou, Huiping
Producer: 20100817
In:
The Journal of pharmacology and experimental therapeutics vol. 334
Availability: No items available.
|
|
2330.
|
|
|
2331.
|
|
|
2332.
|
Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk. [electronic resource] by
- Gatell, José M
- Assoumou, Lambert
- Moyle, Graeme
- Waters, Laura
- Johnson, Margaret
- Domingo, Pere
- Fox, Julie
- Martinez, Esteban
- Stellbrink, Hans-Jürgen
- Guaraldi, Giovanni
- Masia, Mar
- Gompels, Mark
- De Wit, Stephane
- Florence, Eric
- Esser, Stefan
- Raffi, François
- Pozniak, Anton L
Producer: 20180619
In:
AIDS (London, England) vol. 31
Availability: No items available.
|
|
2333.
|
Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants. [electronic resource] by
- Perrier, Marine
- Désiré, Nathalie
- Storto, Alexandre
- Todesco, Eve
- Rodriguez, Christophe
- Bertine, Mélanie
- Le Hingrat, Quentin
- Visseaux, Benoit
- Calvez, Vincent
- Descamps, Diane
- Marcelin, Anne-Geneviève
- Charpentier, Charlotte
Producer: 20190111
In:
PloS one vol. 13
Availability: No items available.
|
|
2334.
|
|
|
2335.
|
Long-Acting Cabotegravir Protects Macaques Against Repeated Penile Simian-Human Immunodeficiency Virus Exposures. [electronic resource] by
- Dobard, Charles
- Makarova, Natalia
- Nishiura, Kenji
- Dinh, Chuong
- Holder, Angela
- Sterling, Mara
- Lipscomb, Jonathan
- Mitchell, James
- Deyounks, Frank
- Garber, David
- Khalil, George
- Spreen, William
- Heneine, Walid
- García-Lerma, J Gerardo
Producer: 20210216
In:
The Journal of infectious diseases vol. 222
Availability: No items available.
|
|
2336.
|
Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World Data. [electronic resource] by
- Byrd, Kathy K
- Hou, John G
- Hazen, Ron
- Kirkham, Heather
- Suzuki, Sumihiro
- Clay, Patrick G
- Bush, Tim
- Camp, Nasima M
- Weidle, Paul J
- Delpino, Ambrose
Producer: 20200514
In:
Journal of acquired immune deficiency syndromes (1999) vol. 82
Availability: No items available.
|
|
2337.
|
|
|
2338.
|
|
|
2339.
|
Efficacy and safety of dolutegravir-rilpivirine for maintenance of virological suppression in adults with HIV-1: 100-week data from the randomised, open-label, phase 3 SWORD-1 and SWORD-2 studies. [electronic resource] by
- Aboud, Michael
- Orkin, Chloe
- Podzamczer, Daniel
- Bogner, Johannes R
- Baker, David
- Khuong-Josses, Marie-Aude
- Parks, David
- Angelis, Konstantinos
- Kahl, Lesley P
- Blair, Elizabeth A
- Adkison, Kimberly
- Underwood, Mark
- Matthews, Jessica E
- Wynne, Brian
- Vandermeulen, Kati
- Gartland, Martin
- Smith, Kimberly
Producer: 20200609
In:
The lancet. HIV vol. 6
Availability: No items available.
|
|
2340.
|
|